FDA approves Botox injections to treat crow’s feet
09/11/2013 10:01 PM
09/11/2013 10:01 PM
Federal regulators for the first time have approved Botox injections to treat crow’s feet. The Food and Drug Administration said Allergan’s Botox Cosmetic injection is the first drug approved to treat the wrinkles that form on the outside edge of the eyes. Allergan studied the use of the drug in 833 adults with crow’s feet who randomly received Botox or a sham injection. Patients who received Botox had fewer visible wrinkles than those who received the placebo drug.Thumbs up
A computer system underpinning the health care overhaul has completed security testing and is ready to go, the federal government said. The update may ease concerns that the network might not be functional when the uninsured begin shopping for coverage Oct. 1. The computer hub, a frequent target of Republicans, is designed to route data on customers using new insurance exchanges from seven federal agencies, including the Internal Revenue Service and the Social Security Administration.Disney delays ‘Pirates’
Walt Disney Co. has indefinitely delayed the planned summer 2015 release of “Pirates of the Caribbean: Dead Men Tell No Tales,” the fifth film in the action series. The movie is being produced by Jerry Bruckheimer, whose latest Disney film, “The Lone Ranger,” flopped with audiences this summer. The latest “Pirates,” set to again star Johnny Depp, was scheduled to open July 10, 2015. Disney didn’t provide an explanation.Meat industry loses court fight
U.S. and Canadian meat industry groups lost a bid in federal court to temporarily block enforcement of country-of-origin food labeling rules. The industry groups argued that the rules, issued by the U.S. Department of Agriculture, violate the Constitution by compelling speech in the form of costly and detailed labels on meat products that will confuse consumers and raise prices. District Judge Ketanji Brown Jackson in Washington disagreed.Mortgage applications fall
Mortgage applications in the U.S. plunged last week to the lowest since October 2008 as rising borrowing costs led to a slump in home refinancing. The Mortgage Bankers Association’s index dropped 13.5 percent in the period ending Sept. 6, the Washington-based trade group said.